These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 1625197
1. Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog. Abels BC, Callis JT, Branch RA, Sabra R. J Pharmacol Exp Ther; 1992 Jul; 262(1):166-72. PubMed ID: 1625197 [Abstract] [Full Text] [Related]
2. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A. Callis JT, Kuan CJ, Branch KR, Abels BC, Sabra R, Jackson EK, Branch RA. J Pharmacol Exp Ther; 1989 Mar; 248(3):1123-9. PubMed ID: 2703965 [Abstract] [Full Text] [Related]
3. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist. Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR, Zimmerman MB. J Pharmacol Exp Ther; 1987 Sep; 242(3):784-90. PubMed ID: 3656113 [Abstract] [Full Text] [Related]
4. Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX. Griebel G, Saffroy-Spittler M, Misslin R, Remmy D, Vogel E, Bourguignon JJ. Psychopharmacology (Berl); 1991 Sep; 103(4):541-4. PubMed ID: 2062988 [Abstract] [Full Text] [Related]
5. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor. Levens N, Beil M, Jarvis M. J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017 [Abstract] [Full Text] [Related]
6. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA, Cash WD. J Pharmacol Exp Ther; 1987 May; 241(2):415-20. PubMed ID: 2883298 [Abstract] [Full Text] [Related]
7. Effects of hyperosmotic mannitol infusion on hemodynamics of dog kidney. Behnia R, Koushanpour E, Brunner EA. Anesth Analg; 1996 May; 82(5):902-8. PubMed ID: 8610896 [Abstract] [Full Text] [Related]
8. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor. Levens N, Beil M, Schulz R. J Pharmacol Exp Ther; 1991 Jun; 257(3):1013-9. PubMed ID: 2046018 [Abstract] [Full Text] [Related]
9. Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes. Behnke N, Müller W, Neumann J, Schmitz W, Scholz H, Stein B. J Pharmacol Exp Ther; 1990 Sep; 254(3):1017-23. PubMed ID: 2168481 [Abstract] [Full Text] [Related]
10. Effects of CGS-15943A on the relaxations produced by adenosine analogs in human blood vessels. Sabouni MH, Brown GL, Kotake AN, Douglas FL, Mustafa SJ. Eur J Pharmacol; 1990 Oct 23; 187(3):525-30. PubMed ID: 2073926 [Abstract] [Full Text] [Related]
11. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart. Felsch A, Stöcker K, Borchard U. Eur J Pharmacol; 1994 Oct 03; 263(3):261-8. PubMed ID: 7843263 [Abstract] [Full Text] [Related]
12. Direct measurement of renal medullary blood flow in the dog. Strick DM, Fiksen-Olsen MJ, Lockhart JC, Roman RJ, Romero JC. Am J Physiol; 1994 Jul 03; 267(1 Pt 2):R253-9. PubMed ID: 8048629 [Abstract] [Full Text] [Related]
13. Patterns of renal function in hypertension due to unilateral renal artery occlusion. Tsuji Y, Goldfarb DA, Masaki Z, Ferrario CM. Clin Exp Hypertens A; 1992 Jul 03; 14(6):1067-81. PubMed ID: 1358485 [Abstract] [Full Text] [Related]
14. Glomerular haemodynamics during renal artery clamping and haemorrhage in the dog. Heller J, Horácek V. Exp Physiol; 1997 Sep 03; 82(5):935-42. PubMed ID: 9331559 [Abstract] [Full Text] [Related]
15. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex. Jarvis MF, Williams M, Do UH, Sills MA. Mol Pharmacol; 1991 Jan 03; 39(1):49-54. PubMed ID: 1987452 [Abstract] [Full Text] [Related]
16. Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dog. Krause SM, Walsh TF, Greenlee WJ, Ranaei R, Williams DL, Kivlighn SD. J Am Soc Nephrol; 1997 Jul 03; 8(7):1061-71. PubMed ID: 9219155 [Abstract] [Full Text] [Related]
17. Intrarenal vascular sites of action of adenosine and glucagon. Aki Y, Shoji T, Hasui K, Fukui K, Tamaki T, Iwao H, Abe Y. Jpn J Pharmacol; 1990 Dec 03; 54(4):433-40. PubMed ID: 2087004 [Abstract] [Full Text] [Related]
18. Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release. Zäll S, Edén E, Winsö I, Volkmann R, Sollevi A, Ricksten SE. Anesth Analg; 1990 Dec 03; 71(6):631-6. PubMed ID: 2240636 [Abstract] [Full Text] [Related]
19. Renal hemodynamic effects of exogenously administered adenosine and polyadenylic acid. Thompson CI, Spielman WS. Am J Physiol; 1992 Nov 03; 263(5 Pt 2):F816-23. PubMed ID: 1443173 [Abstract] [Full Text] [Related]
20. Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. Sigmon DH, Beierwaltes WH. J Am Soc Nephrol; 1994 Dec 03; 5(6):1369-77. PubMed ID: 7894004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]